These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32223656)

  • 21. Role of biologics targeting type 2 airway inflammation in asthma: what have we learned so far?
    Parulekar AD; Diamant Z; Hanania NA
    Curr Opin Pulm Med; 2017 Jan; 23(1):3-11. PubMed ID: 27820746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
    Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
    MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights.
    Elieh Ali Komi D; Bjermer L
    Clin Rev Allergy Immunol; 2019 Apr; 56(2):234-247. PubMed ID: 30506113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokines and cytokine-specific therapy in asthma.
    Desai D; Brightling C
    Adv Clin Chem; 2012; 57():57-97. PubMed ID: 22870587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine and anti-cytokine therapy for asthma.
    Simon HU
    Curr Allergy Asthma Rep; 2006 Mar; 6(2):117-21. PubMed ID: 16566861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Th2 cytokine antagonists: potential treatments for severe asthma.
    Hansbro PM; Scott GV; Essilfie AT; Kim RY; Starkey MR; Nguyen DH; Allen PD; Kaiko GE; Yang M; Horvat JC; Foster PS
    Expert Opin Investig Drugs; 2013 Jan; 22(1):49-69. PubMed ID: 23126660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma.
    Herbert C; Hettiaratchi A; Webb DC; Thomas PS; Foster PS; Kumar RK
    Clin Exp Allergy; 2008 May; 38(5):847-56. PubMed ID: 18307529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
    Fajt ML; Wenzel SE
    J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of mast cells in airway remodeling.
    Okayama Y; Ra C; Saito H
    Curr Opin Immunol; 2007 Dec; 19(6):687-93. PubMed ID: 17761410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 inflammation in asthma--present in most, absent in many.
    Fahy JV
    Nat Rev Immunol; 2015 Jan; 15(1):57-65. PubMed ID: 25534623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation.
    Peters-Golden M; Sampson AP
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S37-42; discussion S43-8. PubMed ID: 12532085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of cytokines in atopic asthma.
    Finiasz M; Otero C; Bezrodnik L; Fink S
    Curr Med Chem; 2011; 18(10):1476-87. PubMed ID: 21428894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prostaglandin D
    Domingo C; Palomares O; Sandham DA; Erpenbeck VJ; Altman P
    Respir Res; 2018 Sep; 19(1):189. PubMed ID: 30268119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on emerging drugs for asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):37-42. PubMed ID: 22292562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards targeting resolution pathways of airway inflammation in asthma.
    Barnig C; Frossard N; Levy BD
    Pharmacol Ther; 2018 Jun; 186():98-113. PubMed ID: 29352860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New perspectives on mechanisms underlying chronic allergic inflammation and asthma in 2007.
    Broide D
    J Allergy Clin Immunol; 2008 Sep; 122(3):475-80. PubMed ID: 18694589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Inhibitory Effect of a Lysophosphatidic Acid 2 Agonist on Allergen-Driven Airway Inflammation.
    Knowlden SA; Hillman SE; Chapman TJ; Patil R; Miller DD; Tigyi G; Georas SN
    Am J Respir Cell Mol Biol; 2016 Mar; 54(3):402-9. PubMed ID: 26248018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-antibiotic properties of tetracyclines as anti-allergy and asthma drugs.
    Joks R; Durkin HG
    Pharmacol Res; 2011 Dec; 64(6):602-9. PubMed ID: 21501686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging drugs for asthma.
    Quirce S; Bobolea I; Barranco P
    Expert Opin Emerg Drugs; 2012 Jun; 17(2):219-37. PubMed ID: 22607631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment.
    Bagnasco D; Heffler E; Testino E; Passalacqua G; Canonica GW
    Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):113-120. PubMed ID: 30632416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.